Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody. 2022

Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.

As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for highly potent monoclonal antibodies (mAbs) that are resistant against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VoCs). Here, we evaluate the potency of the previously described mAb J08 against these variants using cell-based assays and delve into the molecular details of the binding interaction using cryoelectron microscopy (cryo-EM) and X-ray crystallography. We show that mAb J08 has low nanomolar affinity against most VoCs and binds high on the receptor binding domain (RBD) ridge, away from many VoC mutations. These findings further validate the phase II/III human clinical trial underway using mAb J08 as a monoclonal therapy.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D057134 Antibodies, Neutralizing Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. Neutralizing Antibodies,Antibody, Neutralizing,Neutralizing Antibody

Related Publications

Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
January 2021, Frontiers in immunology,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
March 2021, Cell reports. Medicine,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
May 2022, Cell research,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
January 2021, Frontiers in immunology,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
June 2021, Science advances,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
March 2021, National science review,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
September 2020, bioRxiv : the preprint server for biology,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
January 2020, Frontiers in immunology,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
April 2022, Signal transduction and targeted therapy,
Jonathan L Torres, and Gabriel Ozorowski, and Emanuele Andreano, and Hejun Liu, and Jeffrey Copps, and Giulia Piccini, and Lorena Donnici, and Matteo Conti, and Cyril Planchais, and Delphine Planas, and Noemi Manganaro, and Elisa Pantano, and Ida Paciello, and Piero Pileri, and Timothée Bruel, and Emanuele Montomoli, and Hugo Mouquet, and Olivier Schwartz, and Claudia Sala, and Raffaele De Francesco, and Ian A Wilson, and Rino Rappuoli, and Andrew B Ward
April 2021, Communications biology,
Copied contents to your clipboard!